Senesco Technologies Reports Second Quarter Fiscal 2012 Financial Results

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE Amex: SNT) today reported financial results for the second quarter of fiscal year 2012 which ended on December 31, 2011. Highlights of the second quarter and recent weeks include: Completed a $2 million equity financing Re-structured its research and development agreement with Rahan Meristem (1998) Ltd Demonstrated SNS01-T synergy with lenalidomide in a cancer model Presented at the 53rd Annual Meet

Feed Date: 
February 15, 2012